Cargando…
Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer
Cancer chemotherapy for haemodialysis patients has never been established. To elucidate the feasibility of cisplatin-based combination chemotherapy for haemodialysis patients with lung cancer, a dose escalation study was conducted. Five haemodialysis patients with lung cancer were treated with cispl...
Autores principales: | Watanabe, R, Takiguchi, Y, Moriya, T, Oda, S, Kurosu, K, Tanabe, N, Tatsumi, K, Nagao, K, Kuriyama, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376779/ https://www.ncbi.nlm.nih.gov/pubmed/12556954 http://dx.doi.org/10.1038/sj.bjc.6600687 |
Ejemplares similares
-
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507
por: Sekine, I, et al.
Publicado: (2003) -
First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
por: Athanassiou, A. E., et al.
Publicado: (1989) -
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000) -
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
por: Goto, K, et al.
Publicado: (2004) -
Combination Chemotherapy with Cyclophosphamide, Vincristine, Cisplatin and Etoposide(COPE) Combined with Radiotherapy for Small Cell Lung Cancer
por: Nam, Yong Jin, et al.
Publicado: (1995)